Combexin

康百新

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCombexin
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsLung NeoplasmsRectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnhui Lande Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Lande Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsLung NeoplasmsRectal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A